Summary

MRI和PET心肌梗死小鼠模型

Published: December 19, 2013
doi:

Summary

We describe how to perform MRI and PET imaging of the mouse heart. The protocol is tailored to assess treatment efficacy in models of myocardial infarction and heart failure.

Abstract

心肌梗死是导致死亡的,在西方世界的主要原因之一。小鼠心脏对人的心脏的相似性使得它用于测试新的治疗策略的理想模型。

体内磁共振成像(MRI)给出了心脏的美景无创性有明确的解剖细节,可用于精确功能评估。造影剂可提供组织活力的基本措施,但这些都是非特异性的。正电子发射断层扫描(PET)是一种补充技术,它是高度特异性的分子成像,但缺乏MRI的解剖细节。一起使用,这些技术提供了一个敏感,特异和定量工具,用于疾病和恢复心脏的治疗后的评估。

在本文中我们将介绍这些方法是如何在急性心肌梗死小鼠模型进行的。该程序描述ħERE被设计为假定的保护药物治疗的评估。我们使用磁共振成像测量收缩功能和心肌梗死面积与后期钆增强和PET与氟脱氧葡萄糖(FDG),以评估在梗死区的代谢功能。本文侧重于实用方面,如切片规划,准确的门,药物释放,图像分割,和多式联运配准。这里介绍的方法,可以实现良好的重复性和精度保持较高的吞吐量。

Introduction

In order to measure the efficacy of new treatment strategies for myocardial infarction (MI) in preclinical studies, the assessment of the acute stage as well as long-term outcome is required1. Methods such as histopathology, intracardiac catheters2, and ex vivo heart models3 are commonly used for preclinical studies in mice. It is impossible, however, to follow up treatment with ex vivo or highly invasive methods. Noninvasive measurement techniques as in vivo magnetic resonance imaging (MRI) and positron emission tomography (PET) allow longitudinal experimental designs for disease staging in single subjects. Cine-MRI is used to derive global functional parameters such as left ventricular mass (LVM), ejection fraction (EF) and cardiac output (CO). In addition, after the injection of a gadolinium contrast agent, due to impaired perfusion and washout in the infarction, tissue viability can be assessed with late gadolinium enhancement (LGE) MRI. Complementarily, PET offers a sensitive measure of radiolabeled molecules in order to assess tissue metabolism. The high accuracy of these techniques permits significant reductions in the number of animals required for testing new drugs targeting MI.

The PET and MRI procedures are involved, and without a carefully designed protocol reproducibility is hard to maintain. Procedures established in the clinic for patients require substantial modification for use in mice, due to their considerably faster heart rate and smaller dimensions of the heart4. There is wide variation between individual subjects, both at baseline and in response to induced injury, so a considerable number of mice are needed to establish treatment efficacy.

In this report, we describe our method for sequential PET/MRI imaging of the mouse heart. Both modalities use intravenous contrast agents, which are delivered through the tail vein. MRI consists of standard assessment with Cine-MRIwith an optimal protocol for LGE as described in our previous work6. The entire MRI procedure lasts 30 min. We have obtained consistent fittings for the beds of our instruments so it is possible to transfer the animal on a platform with the same monitoring and anesthetic delivery apparatus between the machines. The PET scan lasts 45 min with in situ injection once the scan is started. The final step is to measure the parameters from both MRI and PET images following coregistration.

Protocol

All components of this study were carried out in accordance with the UK Animals (Scientific Procedures) Act, 1986, and with the approval of the University of Cambridge Ethical Review Panel. 1. Animal Preparation Induce infarcts with a surgical intervention7,8. For measuring at the acute stage, perform imaging 24 hr after intervention. Prepare a thin syringe tubing for drug delivery with a 25 G needle at one extremity and a syringe with a 25 G needle at the othe…

Representative Results

One of the advantages of using MRI is that a longitudinal design can be used in order to stage disease. This is especially important when evaluating novel compounds, as the time course of effect may not be known. Variations in heart volumes due to the disease progression in the same animal are shown in Figure 4. The figure clearly shows the effects of remodeling post myocardial infarction. Correct slice geometry is crucial for the success of a cardiac MRI experiment. Represent…

Discussion

PET/MRI is a comprehensive measurement method for the noninvasive and longitudinal evaluation of systolic function, tissue viability and specific metabolic markers in mouse models of myocardial infarction. Here we have described a protocol for performing MRI and PET sequentially, where coregistration is simplified by the transfer of the same bed between systems. This strategy, also adopted by manufacturers of clinical systems11, does not require a combined PET/MRI scanner and can be performed with standard equ…

Divulgations

The authors have nothing to disclose.

Acknowledgements

We are grateful for funding from the British Heart Foundation to TK and to the UK Medical Research Council for a postgraduate research studentship to GB.

Materials

Material name Company Catalogue number Comments
Gadovist Bayer Schering Pharma PL 00010/0535
FDG IBA Molecular
Equipment
Material name Company Catalog number Comments
Bruker BioSpec 47/40 Bruker
Bruker mouse bed Bruker This bed includes tubing for anesthesia delivery and scavenging.
12 cm diameter birdcage transmitter Bruker T5346
2 cm diameter surface coil receiver Bruker T7027
Red Dot Neonatal monitoring electrodes 3M P/N: 2330
Monitoring equipment SA Systems The monitoring kit includes respiratory pillow and rectal probe for temperature measurements.
Anesthesia equipment General Anesthetic Services
Induction box Vet Tech Solutions LTD
Cambridge split-magnet PET/MRI scanner University of Cambridge A custom built PET/MRI scanner22 was used to perform the PET, its PET performance similar to an F120 micropet scanner23
Segment software Medviso, Lund University Freely available
SPM-mouse University of Cambridge Freely available

References

  1. Borst, O., et al. Methods employed for induction and analysis of experimental myocardial infarction in mice. Cell. Physiol. Biochem. 28, 1-12 (2011).
  2. Pacher, P., Nagayama, T., Mukhopadhyay, P., Bátkai, S., Kass, D. A. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and. 3, 1422-1434 (2008).
  3. Larsen, T. S., et al. The isolated working mouse heart: methodological considerations. Pflügers Arch. 437, 979-985 (1999).
  4. Epstein, F. H. MR in mouse models of cardiac disease. NMR Biomed. 20, 238-255 (2007).
  5. Schneider, J. E., Wiesmann, F., Lygate, C. A., Neubauer, S. How to perform an accurate assessment of cardiac function in mice using high-resolution magnetic resonance imaging. J. Cardiov. Magn. Reson. 8, 693-701 (2006).
  6. Buonincontri, G., Methner, C., Krieg, T., Carpenter, T. A., Sawiak, S. J. A fast protocol for infarct quantification in mice. J. Magn. Reson. Imaging. , (2013).
  7. Methner, C., Schmidt, K., Cohen, M. V., Downey, J. M., Krieg, T. Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts. Am. J. Physiol. 299, 1262-1264 (2010).
  8. Methner, C., et al. Protection through postconditioning or a mitochondria-targeted S-nitrosothiol is unaffected by cardiomyocyte-selective ablation of protein kinase. , (2013).
  9. Heiberg, E., et al. Design and validation of Segment–freely available software for cardiovascular image analysis. BMC Med. Imaging. 10, 1 (2010).
  10. Sawiak, S. J., Wood, N. I., Williams, G. B., Morton, A. J., Carpenter, T. A. Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry. Neurobiol. Dis. 33, 20-27 (2009).
  11. Zaidi, H., et al. Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys. Med. Biol. 56, 3091-3106 (2011).
  12. Thomas, D., et al. T1-weighted cine FLASH is superior to IR imaging of post-infarction myocardial viability at 4.7T. J. Cardiov. Magn. Reson. 8, 345-352 (2006).
  13. Protti, A., Sirker, A., Shah, A. M., Botnar, R. Late gadolinium enhancement of acute myocardial infarction in mice at 7T: cine-FLASH versus inversion recovery. J. Magn. Reson. Imaging. 32, 878-886 (2010).
  14. Bohl, S., et al. Advanced methods for quantification of infarct size in mice using three-dimensional high-field late gadolinium enhancement MRI. Am. J. Physiol. 296, 1200-1208 (2009).
  15. Chapon, C., Herlihy, A. H., Bhakoo, K. K. Assessment of myocardial infarction in mice by late gadolinium enhancement MR imaging using an inversion recovery pulse sequence at 9.4T. J. Cardiov. Magn. Reson. 10, 6 (2008).
  16. Price, A. N., et al. Cardiovascular magnetic resonance imaging in experimental models. The open cardiov medicine journal. 4, 278-292 (2010).
  17. Hiba, B., Richard, N., Thibault, H., Janier, M. Cardiac and respiratory self-gated cine MRI in the mouse: comparison between radial and rectilinear techniques at 7T. Magn. Reson. Med. 58, 745-753 (2007).
  18. Buonincontri, G., et al. PET/MRI in the infarcted mouse heart with the Cambridge split magnet. Nucl. Instrum. Methods Phys. Res. A. , (2012).
  19. Büscher, K., et al. Isochronous assessment of cardiac metabolism and function in mice using hybrid PET/MRI. J. Nucl. Med. 51, 1277-1284 (2010).
  20. Berr, S. S., et al. Images in cardiovascular medicine. Serial multimodality assessment of myocardial infarction in mice using magnetic resonance imaging and micro-positron emission tomography provides complementary information on the progression of scar formation. Circulation. 115, 428-429 (2007).
  21. Lee, W. W., et al. PET/MRI of inflammation in myocardial infarction. J. Am. Coll. Cardiol. 59, 153-163 (2012).
  22. Lucas, A. J., et al. Development of a combined microPET-MR system. Technol. Cancer Res. Treat. 5, 337-341 (2006).
  23. Hawkes, R. C., Fryer, T. D., Siegel, S., Ansorge, R. E., Carpenter, T. A. Preliminary evaluation of a combined microPET-MR system. Technol. Cancer Res. Treat. 9, 53-60 (2010).
check_url/fr/50806?article_type=t

Play Video

Citer Cet Article
Buonincontri, G., Methner, C., Carpenter, T. A., Hawkes, R. C., Sawiak, S. J., Krieg, T. MRI and PET in Mouse Models of Myocardial Infarction. J. Vis. Exp. (82), e50806, doi:10.3791/50806 (2013).

View Video